XLV241108P105000
- 0.00
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday as US Heads to Polls for 2024 Presidential Elections
Direct hit on the USA election | Trump VS Harris, who will win?
The 2024 US presidential election will officially vote on November 5, kicking off a critical battle that will determine the future direction of the United States.
Direct hit on the USA election: When is the earliest possible outcome of this election?
The earliest time the results of this year's usa election will be announced. Market volatility is likely to soar, traders need to do risk management.
Nvidia replaces Intel to join the Dow, and the chip industry welcomes a new generation of leaders.
After intel's stock price plummeted and its weight approached "weightlessness", nvidia is about to replace it as a component stock of the Dow, marking the change of chip giants.
【Real-time Tracking】Trump vs. Harris, who will ultimately take over the White House?
On November 5th, USA will hold the 60th presidential election, the current vice president Harris and former president Trump will officially compete. Finance Associated Press will track and report the latest developments of this election, so please stay tuned.
Futu Morning Post | Countdown to the election! The panic index VIX is burning high and uncertainty is haunting the market nerves; Up nearly 13% after hours! Palantir raises full-year revenue guidance
Jpmorgan warns: If Trump wins on Wednesday, the Fed may pause the easing cycle as early as December; Will the US stock market hit new highs after the election? Jpmorgan: FOMO psychology boosts, S&P may hit 6100 points by the end of the year; US polls: Harris and Trump are neck and neck in key 'swing states'.
US stocks closed: Trump, Harris concept stocks rose together, Chinese concept stocks remained stable and rose.
1. The market is filled with a wait-and-see attitude, with all three major indexes collectively falling. 2. Trump's media technology group rebounded after hitting bottom. 3. Photovoltaic and clean energy concept stocks strengthened collectively. 4. Reports claim that Nvidia will distribute Super Micro Computer orders to other suppliers.
Viking Stock Drops 13% After Jumping 9% on Obesity Drug Data
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
Nvidia Joining Dow Jones Industrial Average: Where Tech Giant Ranks In The Index, Why Sherwin-Williams Addition Could Be More Important
8 High-momentum Stocks Set for Success – Oppenheimer
Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
Healthcare Services Stocks Could Benefit From Harris Win, Oppenheimer Says
AbbVie Analyst Ratings
Peering Into Danaher's Recent Short Interest
Inquiry Into Danaher's Competitor Dynamics In Life Sciences Tools & Services Industry
New weight loss drug CagriSema planned to be launched by novo-nordisk a/s is expected to alleviate the problem of rebound after discontinuation, with a minimum weight loss of 25%!
CagriSema combines the two ingredients of semaglutide and pancreatic amylase, is expected to achieve the best efficacy in history with a 25% weight loss, compared to the previous generation of weight loss drug Wegovy, it will not bring additional side effects, and is expected to alleviate gastrointestinal side effects such as nausea and vomiting.
USA election, who will win? The two main candidates are battling in the 'swing states', this guide for watching and trading is worth collecting!
This may determine the direction of the US economy for the next four years. This may determine the direction of the US economy for the next four years.
Breaking News | Viking surges more than 20% pre-market, significant progress in weight loss drug research.
Viking announced that its experimental drug VK2735 can more effectively reduce patient weight at higher doses compared to the early formulation, leading to a significant pre-market surge.